|
If you have a moderately or severely weakened immune system, it’s more important than ever to have a COVID-19 action plan.
The Food and Drug Administration recently announced that the therapeutic agent EVUSHELD is not currently authorized for emergency use in the U.S. This monoclonal antibody had been prescribed to people with moderately to severely compromised immune systems to help prevent COVID-19 infection, but the latest data suggests it’s unlikely to be effective against the Omicron subvariants dominating at this time.
These steps can help protect those with weakened immune systems and others against severe outcomes from COVID-19:
|
|
|
|
